Advanced Search


Study ID Status Title Patient Level Data
200147 Completed Safety and immunogenicity study of 2 formulations of GSK Biologicals’ varicella vaccines given as a 2-dose course in the second year of life.
200149 Active, Not Recruiting A Randomized, Multi-Center, Blinded, Placebo-Controlled Study Of Mapatumumab ([HGS1012], A Fully Monoclonal Antibody To TRAIL-R1) In Combination With Sorafenib As A First-Line Therapy In Subjects With Advanced Hepatocellular Carcinoma
200158 Completed Risk factors associated with pertussis among infants less than one-year of age
200160 Completed Study for evaluation of immunogenicity and reactogenicity of Fluarix/Influsplit SSW 2013/2014 in people 18 years of age and above
200165 Completed Study 200165, A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Compare the Efficacy of a 2-Week Treatment with Fluticasone Propionate Nasal Spray versus Cetirizine in Adult Subjects with Seasonal Allergic Rhinitis (SAR) Study Listed on
200167 Active, Not Recruiting Evidence synthesis to assess comparative efficacy of UMEC/VI versus other treatments for COPD adult patients
200173 Completed Renal Safety of Adefovir Dipivoxil (ADV) in Chinese Patients with Chronic Hepatitis B
200181 Completed A Randomized Double Blinded (Sponsor Unblind), Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Selective Androgen Receptor Modulator (SARM) in Single and Repeat Doses in Healthy Male Subjects
200185 Completed A Randomized, Double-blind (Sponsor Unblinded), Placebo Controlled, Repeat Dose Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 in Type 2 Diabetes Patients Taking Metformin Study Listed on
200186 Terminated A Randomised, Double-blind (Sponsor Unblind), Placebo-controlled, Two Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of Single or Repeat Doses of GSK2793660 in Healthy Subjects
200187 Completed Epidemiology study of malariometric determinants in selected Post-Approval Programme study sites in sub-Saharan Western Africa
200188 Completed Immunogenicity and safety study of GSK Biologicals' Quadrivalent Split Virion Influenza Vaccine (GSK2321138A) Fluarix/Influsplit Tetra® (2013/2014 season) in adults 18 years of age and older
200190 Completed Immunogenicity and safety study of GSK Biologicals’ Trivalent Split Virion Influenza Vaccine (GSK1536489A) Fluviral™ (2013-2014 Season) in adults aged 18 years and older
200207 Terminated A Double Blind, Placebo Controlled, Single and Repeat Dose Escalation Study of GSK2838232 with and without Ritonavir for 8-11 days in Healthy Subjects
200208 Terminated An open label, experimental medicine investigation of the safety and tolerability of 400 mg b.i.d. GSK2586184 in patients with moderate to severely active ulcerative colitis. Study Listed on
200209 Completed A Prospective Study of Sexual Function in Men Taking Dutasteride for the Treatment of Androgenetic Alopecia
200210 Active, Not Recruiting First Line and Sequential Use of Pazopanib Followed by Mammalian Target of Rapamycin (mTOR) Inhibitor Therapy among Patients with Advanced/Metastatic Renal Cell Carcinoma in a United States Community Oncology Setting
200211 Active, Not Recruiting Persistence and Compliance among United States Patients Receiving Pazopanib or Sunitinib as First‐Line Therapy for Advanced Renal Cell Carcinoma
200215 Active, Not Recruiting The epidemiology, management patterns, and direct costs of treating malignant melanoma: a retrospective and prospective observational survey using the Canadian Melanoma Research Network (CMRN) Patient Registry
200217 Active, Not Recruiting Treatment retention rate of paroxetine CR in the naturalistic setting (A pilot investigation)
200220 Completed A systematic review and network meta-analysis of IPX066 and other common therapies for management of symptoms in patients with advanced Parkinson’s disease (patients experiencing wearing-off on levodopa therapy)
200226 Completed Adjusting for treatment crossover in a Phase 2 trial of dabrafenib and trametinib combination therapy in patients with metastatic melanoma
200227 Active, Not Recruiting HO-13-9058 - Indirect treatment comparison (ITC) of mepolizumab versus omalizumab in the treatment of adults and adolescents (aged >=12 years) with severe asthma
200229 Completed An Open Label, Randomized, Two Part Study to Evaluate the CYP2C8- and OATP1B1-Mediated Drug-Drug Interaction Potential of GSK1278863 with Pioglitazone and Rosuvastatin as Victims and Trimethoprim as Perpetrator in Healthy Adult Volunteers Study Listed on



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.